AstraZeneca admits huge Covid-19 vaccine shortfall for EU

Pascal Soriot, CEO of AstraZeneca, said to European lawmakers the company would deliver to the EU less than half the amount of Covid-19 vaccine doses that it pledged for the first quarter of 2021. The undersupply torpedoed the EU’s plan to use AstraZeneca as its main first vaccine during the first quarter.
Soriot also said, "we hope that by Q2 (the April-May-June second quarter), we can catch up to where we would like to be."
EU officials say ramped up deliveries from April by the Anglo-Swedish company and by BioNTech/Pfizer and Moderna mean that the 27-nation bloc remains on track to reach its goal of fully vaccinating 70% of adults by mid-September.